Delta Waves Sleep Disorders and Research Center

Colorado Springs, Colorado 80918

0 studies enrolling now · 6 studies all time

What they study most

Crohn's Disease, Healthy Volunteers, Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), Obstructive Sleep Apnea, Ulcerative Colitis

Studies at this site

• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy — Stopped early
• A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease — Completed
• Wake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) and Healthy Participants — Completed
• Study of TAK-925 in Participants With Obstructive Sleep Apnea (OSA) Who Are Experiencing Excessive Daytime Sleepiness (EDS) Despite Adequate Use of Continuous Positive Airway Pressure (CPAP) — Completed